• Can changes in EEG improve neuropathic pain treatments - read Oct newsletter.
  • Nine posters ready to reveal at the SfN virtual conference 8-11 Nov, booth 1818.
  • Joined-up preclinical and clinical trials to advance psilocybin drug development
  • Transpharmation joins HaPpY team to help break the vicious cycle of chronic pain & mood disorders, see News for details
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • New state-of-the-art premises at Discovery Park, Kent


News you can use

Recognised by drug developers world-wide, Transpharmation’s client base continues to grow. With the expansion of therapeutic indications offered, the move to new, state of the art research facilities at Discovery Park in Kent is perfectly timed to hit the ground running from January 2021. With a vast array of laboratory and office space, managed by the hugely experienced company Agenda Life Sciences, Transpharmation’s scientists will have everything they need in place to deliver scientific excellence, remaining focussed on the important drug discovery work we carry out for our clients. 

Discovery Park, home to many specialist research companies, was recently named a Life Sciences Opportunity Zone by the UK Government’s Offices for Life Sciences. This multi-million pound site is known for its heritage of scientific excellence and delivery of new treatments for patients. With strong transport links to
airports, trains and ports it is ideally positioned for Transpharmation’s growing global customer portfolio.

Whilst Transpharmation will retain their facilities at The London Bioscience Innovation Centre, Royal Veterinary College and Trinity College Institute of Neuroscience, Dublin, the move to Discovery Park, on their 10th year anniversary, is a pivotal point in the company’s history and sets the agenda for their future growth.

pdfOfficial press release


Start a Conversation

preclinical +44 (0)203 633 2807

clinical trials +353 (0)1896 42 60

clinical research +48 515 244 120

EEG contact@transpharmation.co.uk

Copyright ©2021 Transpharmation Ltd. Website created by Identity Ipswich Web Design